

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * oxygen transport (GO:0015671) | 6.37948658 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.82235134 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.82235134 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.62441384 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.53961736 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.47723117 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.47723117 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.47723117 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.47723117 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 5.47723117 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.47723117 |
| 12 | detection of other organism (GO:0098543) | 5.44271005 |
| 13 | detection of bacterium (GO:0016045) | 5.39448499 |
| 14 | * gas transport (GO:0015669) | 5.25188155 |
| 15 | response to peptidoglycan (GO:0032494) | 5.20813931 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.10531718 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.83010029 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.69230969 |
| 19 | neutrophil activation (GO:0042119) | 4.68585445 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.64798465 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.49464248 |
| 22 | cellular extravasation (GO:0045123) | 4.46603586 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.42831824 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.27511445 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.23998198 |
| 26 | granulocyte activation (GO:0036230) | 4.23217752 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.18800023 |
| 28 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.15137352 |
| 29 | respiratory burst (GO:0045730) | 4.13900857 |
| 30 | leukocyte aggregation (GO:0070486) | 4.13567274 |
| 31 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.06967434 |
| 32 | response to host immune response (GO:0052572) | 4.05511609 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.05511609 |
| 34 | response to interleukin-15 (GO:0070672) | 4.02028878 |
| 35 | microglial cell activation (GO:0001774) | 4.00669018 |
| 36 | hemoglobin metabolic process (GO:0020027) | 3.98593545 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.98545708 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.94437556 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92981259 |
| 40 | neutrophil mediated immunity (GO:0002446) | 3.91564405 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.81842246 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.80390174 |
| 43 | regulation of mast cell degranulation (GO:0043304) | 3.73885237 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.72978223 |
| 45 | response to host (GO:0075136) | 3.72978223 |
| 46 | response to host defenses (GO:0052200) | 3.72978223 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.69077780 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.68912515 |
| 49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64870983 |
| 50 | cellular response to interleukin-15 (GO:0071350) | 3.63335241 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.60268859 |
| 52 | positive regulation of granulocyte differentiation (GO:0030854) | 3.54391341 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.54131142 |
| 54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.53428515 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.50984986 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.50501970 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 3.48582490 |
| 58 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.43759720 |
| 59 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.43149270 |
| 60 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.42834629 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 3.41043340 |
| 62 | macrophage activation (GO:0042116) | 3.40531170 |
| 63 | erythrocyte development (GO:0048821) | 3.40171034 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.39321486 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.37792424 |
| 66 | regulation of B cell differentiation (GO:0045577) | 3.35587116 |
| 67 | negative regulation of phagocytosis (GO:0050765) | 3.35328110 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 3.35210737 |
| 69 | defense response to fungus (GO:0050832) | 3.34996943 |
| 70 | erythrocyte maturation (GO:0043249) | 3.34471551 |
| 71 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.32307223 |
| 72 | leukocyte degranulation (GO:0043299) | 3.30793184 |
| 73 | myeloid leukocyte mediated immunity (GO:0002444) | 3.27978345 |
| 74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.26029659 |
| 75 | killing of cells of other organism (GO:0031640) | 3.24111635 |
| 76 | disruption of cells of other organism (GO:0044364) | 3.24111635 |
| 77 | myeloid cell development (GO:0061515) | 3.23767326 |
| 78 | cellular response to type I interferon (GO:0071357) | 3.23617355 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.23617355 |
| 80 | response to type I interferon (GO:0034340) | 3.22770408 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 3.16908847 |
| 82 | response to muramyl dipeptide (GO:0032495) | 3.16074035 |
| 83 | regulation of mast cell activation (GO:0033003) | 3.13215393 |
| 84 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.10459860 |
| 85 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.10459860 |
| 86 | negative regulation of interleukin-6 production (GO:0032715) | 3.09042963 |
| 87 | positive thymic T cell selection (GO:0045059) | 3.08276107 |
| 88 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.05502421 |
| 89 | activated T cell proliferation (GO:0050798) | 3.04187465 |
| 90 | negative thymic T cell selection (GO:0045060) | 3.03293769 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.99106058 |
| 92 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.99106058 |
| 93 | negative regulation of type 2 immune response (GO:0002829) | 2.96435080 |
| 94 | superoxide anion generation (GO:0042554) | 2.96320507 |
| 95 | regulation of regulated secretory pathway (GO:1903305) | 2.96221410 |
| 96 | regulation of tolerance induction (GO:0002643) | 2.95654931 |
| 97 | megakaryocyte development (GO:0035855) | 2.94763716 |
| 98 | organ or tissue specific immune response (GO:0002251) | 2.94163888 |
| 99 | negative T cell selection (GO:0043383) | 2.94037359 |
| 100 | response to fungus (GO:0009620) | 2.92268150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.78193826 |
| 2 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.82977335 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73341498 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.36660085 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.32288228 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.27702519 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.16140194 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.05303689 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.03981886 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03620814 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.90715998 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87336862 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79995725 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.71777824 |
| 15 | GATA1_19941826_ChIP-Seq_K562_Human | 2.69165278 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67692924 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.63537204 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.55745990 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.53895184 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52538782 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.49681967 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47031794 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.38779709 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.37890118 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.35049506 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.34694497 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.31590958 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31169324 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.27937032 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22154182 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.22138592 |
| 32 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.20943686 |
| 33 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.20369023 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18997196 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10989477 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 2.09957209 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.09162684 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07606413 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01616160 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.95234995 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93996690 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92975925 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91464436 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.85389530 |
| 45 | GATA2_19941826_ChIP-Seq_K562_Human | 1.83420824 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.74723344 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.72680924 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71875941 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67566139 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65149818 |
| 51 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.58029878 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.57506668 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.57257114 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55798609 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53864782 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51786747 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50148225 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49823779 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46846962 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45784768 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43001896 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42375520 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42293260 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41973326 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38592133 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36828274 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35155114 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31876180 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30667736 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30338020 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29421502 |
| 72 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.28975821 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24907299 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24821470 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24542540 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21615999 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21309775 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20791400 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20717221 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18011090 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16968593 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16353074 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14840361 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13801294 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11586895 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10554809 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09071668 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05411127 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04521372 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03665306 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03148566 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02689200 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99842262 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98801293 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98604309 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92058704 |
| 97 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.90660604 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89405668 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88696409 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87867449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.56834006 |
| 2 | MP0003436_decreased_susceptibility_to | 4.12826717 |
| 3 | MP0003303_peritoneal_inflammation | 3.93171757 |
| 4 | MP0003656_abnormal_erythrocyte_physiolo | 3.58887485 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.26297020 |
| 6 | MP0002419_abnormal_innate_immunity | 3.08349561 |
| 7 | MP0005025_abnormal_response_to | 2.93226994 |
| 8 | MP0009785_altered_susceptibility_to | 2.86041617 |
| 9 | MP0000685_abnormal_immune_system | 2.74283747 |
| 10 | MP0001800_abnormal_humoral_immune | 2.64530671 |
| 11 | MP0001790_abnormal_immune_system | 2.58249303 |
| 12 | MP0005387_immune_system_phenotype | 2.58249303 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.57058822 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.52689919 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.46471978 |
| 16 | MP0004147_increased_porphyrin_level | 2.44295296 |
| 17 | MP0001819_abnormal_immune_cell | 2.43190675 |
| 18 | MP0005671_abnormal_response_to | 2.38860883 |
| 19 | MP0002723_abnormal_immune_serum | 2.34966856 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.33517052 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.30113954 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.24508693 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.21190562 |
| 24 | MP0009278_abnormal_bone_marrow | 2.20979189 |
| 25 | MP0002398_abnormal_bone_marrow | 2.19907049 |
| 26 | MP0002396_abnormal_hematopoietic_system | 2.18835314 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.15604596 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.15604596 |
| 29 | MP0008260_abnormal_autophagy | 2.14688187 |
| 30 | MP0002132_abnormal_respiratory_system | 2.12641651 |
| 31 | MP0002405_respiratory_system_inflammati | 2.10199848 |
| 32 | MP0006082_CNS_inflammation | 2.04330201 |
| 33 | MP0005083_abnormal_biliary_tract | 1.99226147 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.98446700 |
| 35 | MP0000716_abnormal_immune_system | 1.89873107 |
| 36 | MP0002722_abnormal_immune_system | 1.83807686 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.83275098 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.80767336 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.75625161 |
| 40 | MP0003828_pulmonary_edema | 1.71271644 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.66037322 |
| 42 | MP0002429_abnormal_blood_cell | 1.65889565 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.64746380 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.62296338 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.61093263 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.58803929 |
| 47 | MP0003866_abnormal_defecation | 1.57390577 |
| 48 | MP0009764_decreased_sensitivity_to | 1.50556140 |
| 49 | MP0004947_skin_inflammation | 1.48540817 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.41397664 |
| 51 | MP0004381_abnormal_hair_follicle | 1.39135044 |
| 52 | MP0001851_eye_inflammation | 1.33367144 |
| 53 | * MP0008469_abnormal_protein_level | 1.27134660 |
| 54 | MP0000858_altered_metastatic_potential | 1.25033161 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.22729779 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.19356821 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.18052263 |
| 58 | MP0004883_abnormal_blood_vessel | 1.15059557 |
| 59 | MP0005451_abnormal_body_composition | 1.11913942 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.08025178 |
| 61 | MP0005310_abnormal_salivary_gland | 1.05793068 |
| 62 | MP0002998_abnormal_bone_remodeling | 0.97819383 |
| 63 | MP0003075_altered_response_to | 0.97611428 |
| 64 | MP0005164_abnormal_response_to | 0.96319942 |
| 65 | MP0009763_increased_sensitivity_to | 0.90992132 |
| 66 | MP0004510_myositis | 0.89560529 |
| 67 | MP0003878_abnormal_ear_physiology | 0.87418538 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 0.87418538 |
| 69 | MP0000490_abnormal_crypts_of | 0.86991390 |
| 70 | MP0003690_abnormal_glial_cell | 0.84591814 |
| 71 | MP0001663_abnormal_digestive_system | 0.84038646 |
| 72 | MP0000343_altered_response_to | 0.83538904 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.83526146 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.79735431 |
| 75 | MP0004130_abnormal_muscle_cell | 0.78500997 |
| 76 | MP0005390_skeleton_phenotype | 0.76879275 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.75528055 |
| 78 | MP0001873_stomach_inflammation | 0.74168697 |
| 79 | MP0002009_preneoplasia | 0.72547778 |
| 80 | MP0005166_decreased_susceptibility_to | 0.70473045 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.70376333 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 0.67328087 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66833506 |
| 84 | MP0001853_heart_inflammation | 0.63991624 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.63700887 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.61055609 |
| 87 | MP0008874_decreased_physiological_sensi | 0.61027185 |
| 88 | MP0003448_altered_tumor_morphology | 0.60944880 |
| 89 | * MP0003795_abnormal_bone_structure | 0.60156560 |
| 90 | MP0002006_tumorigenesis | 0.59735507 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.55812382 |
| 92 | MP0002928_abnormal_bile_duct | 0.55510531 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.55268705 |
| 94 | MP0008004_abnormal_stomach_pH | 0.54837364 |
| 95 | MP0002933_joint_inflammation | 0.53110561 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.52716954 |
| 97 | * MP0009931_abnormal_skin_appearance | 0.51270797 |
| 98 | * MP0000609_abnormal_liver_physiology | 0.49160923 |
| 99 | MP0000604_amyloidosis | 0.48888047 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.48771727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Abnormality of the heme biosynthetic pathway (HP:0010472) | 7.78915020 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.30843121 |
| 3 | * Hypochromic anemia (HP:0001931) | 6.24088643 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.57412476 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.48122343 |
| 6 | Toxemia of pregnancy (HP:0100603) | 5.36769131 |
| 7 | * Microcytic anemia (HP:0001935) | 5.21013215 |
| 8 | Myositis (HP:0100614) | 4.87723373 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.64826492 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.61852797 |
| 11 | Orchitis (HP:0100796) | 4.35976863 |
| 12 | Stomatitis (HP:0010280) | 4.32362371 |
| 13 | * Abnormal hemoglobin (HP:0011902) | 4.30892811 |
| 14 | Prolonged bleeding time (HP:0003010) | 4.03566272 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.03030499 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.99911683 |
| 17 | Obstructive lung disease (HP:0006536) | 3.99911683 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.99292741 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.97643743 |
| 20 | Optic neuritis (HP:0100653) | 3.97643743 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.94946733 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.81599594 |
| 23 | Poikilocytosis (HP:0004447) | 3.77727766 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.72838757 |
| 25 | Meningitis (HP:0001287) | 3.64902025 |
| 26 | Recurrent skin infections (HP:0001581) | 3.59333720 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.55951158 |
| 28 | Urticaria (HP:0001025) | 3.51951390 |
| 29 | * Polycythemia (HP:0001901) | 3.46641083 |
| 30 | Gingivitis (HP:0000230) | 3.38513494 |
| 31 | Increased IgE level (HP:0003212) | 3.35722347 |
| 32 | Encephalitis (HP:0002383) | 3.31261045 |
| 33 | Cellulitis (HP:0100658) | 3.26271310 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 3.22167964 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.21948710 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.21948710 |
| 37 | Epistaxis (HP:0000421) | 3.02560964 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.97116375 |
| 39 | Vasculitis (HP:0002633) | 2.95874366 |
| 40 | Gingival bleeding (HP:0000225) | 2.86333326 |
| 41 | Chest pain (HP:0100749) | 2.86203793 |
| 42 | Petechiae (HP:0000967) | 2.80651104 |
| 43 | Pustule (HP:0200039) | 2.76983429 |
| 44 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.72433717 |
| 45 | Episodic fever (HP:0001954) | 2.70990853 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.65382999 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.64340313 |
| 48 | Abnormality of the pericardium (HP:0001697) | 2.60830737 |
| 49 | Anorexia (HP:0002039) | 2.57697194 |
| 50 | Recurrent viral infections (HP:0004429) | 2.57423466 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.55715434 |
| 52 | Leukocytosis (HP:0001974) | 2.54477358 |
| 53 | Peritonitis (HP:0002586) | 2.46412791 |
| 54 | T lymphocytopenia (HP:0005403) | 2.45837649 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.43292605 |
| 56 | Abnormality of T cells (HP:0002843) | 2.42661222 |
| 57 | Granulocytopenia (HP:0001913) | 2.42179625 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.41060930 |
| 59 | Reticulocytosis (HP:0001923) | 2.39927208 |
| 60 | Hemoptysis (HP:0002105) | 2.39665285 |
| 61 | * Osteomyelitis (HP:0002754) | 2.35566449 |
| 62 | Abnormal platelet volume (HP:0011876) | 2.35480189 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.34512799 |
| 64 | Increased IgM level (HP:0003496) | 2.31047706 |
| 65 | Arterial thrombosis (HP:0004420) | 2.27891012 |
| 66 | Slow saccadic eye movements (HP:0000514) | 2.27081844 |
| 67 | Abnormality of the fingertips (HP:0001211) | 2.22212569 |
| 68 | Pulmonary embolism (HP:0002204) | 2.18238806 |
| 69 | Acanthocytosis (HP:0001927) | 2.14581169 |
| 70 | Increased serum ferritin (HP:0003281) | 2.14480207 |
| 71 | Sepsis (HP:0100806) | 2.14341318 |
| 72 | Paralysis (HP:0003470) | 2.14258875 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.01774634 |
| 74 | Amyloidosis (HP:0011034) | 2.01189197 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.00307890 |
| 76 | * Hypochromic microcytic anemia (HP:0004840) | 10.2046202 |
| 77 | Colitis (HP:0002583) | 1.99947927 |
| 78 | Hepatosplenomegaly (HP:0001433) | 1.97416408 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 1.96521745 |
| 80 | Agammaglobulinemia (HP:0004432) | 1.94682067 |
| 81 | Bruising susceptibility (HP:0000978) | 1.90440090 |
| 82 | Lymphopenia (HP:0001888) | 1.89434803 |
| 83 | Viral hepatitis (HP:0006562) | 1.89385183 |
| 84 | Eosinophilia (HP:0001880) | 1.88051057 |
| 85 | Purpura (HP:0000979) | 1.87624734 |
| 86 | Skin rash (HP:0000988) | 1.87421334 |
| 87 | * Skin ulcer (HP:0200042) | 1.86178254 |
| 88 | * Abnormality of iron homeostasis (HP:0011031) | 1.86164440 |
| 89 | Glomerulopathy (HP:0100820) | 1.86131222 |
| 90 | Metaphyseal cupping (HP:0003021) | 1.85527140 |
| 91 | Autoimmune hemolytic anemia (HP:0001890) | 1.83708932 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 1.80698788 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.79652688 |
| 94 | Cutaneous photosensitivity (HP:0000992) | 1.78766513 |
| 95 | Vertigo (HP:0002321) | 1.77932578 |
| 96 | * Splenomegaly (HP:0001744) | 1.77795078 |
| 97 | Papilledema (HP:0001085) | 1.77276077 |
| 98 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.75450451 |
| 99 | Difficulty running (HP:0009046) | 1.74738629 |
| 100 | IgM deficiency (HP:0002850) | 1.72229276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.61485443 |
| 2 | MAP2K3 | 3.79320820 |
| 3 | MAP4K1 | 3.37697860 |
| 4 | PRPF4B | 3.19087267 |
| 5 | IRAK4 | 2.88461558 |
| 6 | GRK6 | 2.85568874 |
| 7 | BLK | 2.84162159 |
| 8 | TNK2 | 2.69206371 |
| 9 | ERN1 | 2.64032165 |
| 10 | FES | 2.59330994 |
| 11 | TAOK1 | 2.54071821 |
| 12 | TYK2 | 2.44322086 |
| 13 | MAP3K3 | 2.22385193 |
| 14 | CSK | 2.20845632 |
| 15 | MAP3K11 | 2.14815714 |
| 16 | ZAP70 | 2.12544030 |
| 17 | BTK | 1.93859321 |
| 18 | SYK | 1.84569476 |
| 19 | EPHB1 | 1.81223385 |
| 20 | FGR | 1.71035065 |
| 21 | HCK | 1.70238135 |
| 22 | TAOK2 | 1.57052689 |
| 23 | TXK | 1.55754177 |
| 24 | JAK3 | 1.40344527 |
| 25 | JAK2 | 1.38939376 |
| 26 | LYN | 1.38830281 |
| 27 | MAP3K1 | 1.36293348 |
| 28 | IKBKE | 1.34838655 |
| 29 | SIK3 | 1.34155511 |
| 30 | MARK3 | 1.31595391 |
| 31 | KSR2 | 1.19013171 |
| 32 | YES1 | 1.18459978 |
| 33 | TEC | 1.15233130 |
| 34 | MAP3K13 | 1.11922440 |
| 35 | TBK1 | 1.07762576 |
| 36 | MAP3K6 | 1.06726804 |
| 37 | LCK | 1.06005777 |
| 38 | KIT | 1.04946867 |
| 39 | JAK1 | 1.04338188 |
| 40 | MARK2 | 1.04099056 |
| 41 | TRIB3 | 1.03730832 |
| 42 | TAOK3 | 1.01068795 |
| 43 | PTK2B | 1.00716982 |
| 44 | MAP3K14 | 1.00383015 |
| 45 | ITK | 0.99981557 |
| 46 | CSF1R | 0.92719909 |
| 47 | EIF2AK1 | 0.92289677 |
| 48 | SIK2 | 0.91355950 |
| 49 | PTK6 | 0.87439680 |
| 50 | PRKD2 | 0.86090665 |
| 51 | HIPK2 | 0.84106418 |
| 52 | PIM1 | 0.79035024 |
| 53 | MAP3K5 | 0.78343827 |
| 54 | SMG1 | 0.76488621 |
| 55 | MAP2K4 | 0.75878274 |
| 56 | STK11 | 0.75338182 |
| 57 | PDK1 | 0.75234114 |
| 58 | STK10 | 0.74766269 |
| 59 | CDK19 | 0.73902002 |
| 60 | DYRK1B | 0.69618372 |
| 61 | BMX | 0.68186762 |
| 62 | MAP3K7 | 0.67579982 |
| 63 | MAPK12 | 0.67164459 |
| 64 | PDPK1 | 0.65499025 |
| 65 | IKBKB | 0.65152008 |
| 66 | SGK3 | 0.63806311 |
| 67 | TESK2 | 0.63400111 |
| 68 | MATK | 0.62273154 |
| 69 | FYN | 0.61703439 |
| 70 | IRAK1 | 0.61144532 |
| 71 | LRRK2 | 0.57872346 |
| 72 | WNK1 | 0.56642080 |
| 73 | RPS6KC1 | 0.54340081 |
| 74 | RPS6KL1 | 0.54340081 |
| 75 | PRKCQ | 0.54144758 |
| 76 | MAP3K10 | 0.52919052 |
| 77 | CDK12 | 0.52563800 |
| 78 | BMPR2 | 0.51693863 |
| 79 | DYRK3 | 0.50569908 |
| 80 | MAP3K2 | 0.49976991 |
| 81 | KSR1 | 0.49568491 |
| 82 | RET | 0.48720144 |
| 83 | PIK3CG | 0.47822456 |
| 84 | IRAK2 | 0.46966587 |
| 85 | RAF1 | 0.46564686 |
| 86 | SIK1 | 0.46177917 |
| 87 | SGK2 | 0.45732408 |
| 88 | RPS6KA6 | 0.45477745 |
| 89 | FGFR3 | 0.42092568 |
| 90 | MAPK7 | 0.41114311 |
| 91 | STK38 | 0.40719966 |
| 92 | CDC42BPA | 0.40001744 |
| 93 | CLK1 | 0.38923609 |
| 94 | TGFBR2 | 0.38792709 |
| 95 | MAPKAPK2 | 0.37651375 |
| 96 | MAP2K6 | 0.37464710 |
| 97 | CDK4 | 0.36037190 |
| 98 | EPHA3 | 0.34667168 |
| 99 | MAP3K8 | 0.33882623 |
| 100 | CDK6 | 0.33843708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Malaria_Homo sapiens_hsa05144 | 2.99050014 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.96978604 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81123715 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44957491 |
| 5 | * African trypanosomiasis_Homo sapiens_hsa05143 | 2.29528236 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25632243 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.25032855 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.24896693 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.14809668 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.01150663 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.00060968 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96126208 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.87011578 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.85339952 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80788770 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75899611 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75148377 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70549440 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.70539774 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.67059063 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62210257 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.60324382 |
| 23 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.56849788 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.48348952 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46135309 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44620504 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41873082 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41717939 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36369608 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33143570 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31346412 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.30973910 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30929688 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29247766 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.27944068 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.25272997 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.24040633 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22240899 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22204177 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.20249957 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.19357899 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16487470 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15640327 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03827845 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00362084 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.98293695 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98081633 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91948514 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91357977 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.90750264 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89957059 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86887958 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.86608241 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84274295 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83480258 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82854492 |
| 57 | Endocytosis_Homo sapiens_hsa04144 | 0.82750598 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82623670 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81648753 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80300764 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79554628 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77028443 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76111208 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75768764 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75574131 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.75293325 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.74874209 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74521252 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74221895 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73415977 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72885846 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71929654 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71587635 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70705957 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68378533 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67573461 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67342761 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64692954 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63654234 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63473179 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63455585 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62978753 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62966674 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62129377 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59197564 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58130068 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55474656 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.54899126 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.54129044 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53347443 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52567567 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50353313 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.49462029 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48295962 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.47570345 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45668489 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44924332 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43012129 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42923747 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41579080 |

